• UCLA Health
  • myUCLAhealth
  • School of Medicine
Neurology

UCLA Neurology

Neurology
  • About Us
    • Chair's Welcome
    • Contact Us
    • Department of Neurology Strategic Plan
    • Neurology Chair's Reports
    • Brains of Neurology
    • Publications, News and Events
    • Giving
    • Employment Opportunities
  • Clinical Programs
    • Mary S. Easton Center for Alzheimer's Disease Research at UCLA
    • Behavioral Neurology
    • Epilepsy
    • General Neurology
    • UCLA Goldberg Migraine Program
    • Movement Disorders
    • Multiple Sclerosis
    • The Marilyn Hilton MS Achievement Center at UCLA
    • Neurocritical Care
    • Neurogenetics
    • Neuromuscular
    • Neurophysiology
    • Neuro-Infectious Diseases
    • Neuro-Oncology
    • Neuro-Otology
    • Neuro-Rehabilitation
    • Sleep Disorders
    • Stroke
    • Mary S. Easton Center for Alzheimer's Disease Research at UCLA
    • Behavioral Neurology
    • Epilepsy
    • General Neurology
    • UCLA Goldberg Migraine Program
    • Movement Disorders
    • Multiple Sclerosis
    • The Marilyn Hilton MS Achievement Center at UCLA
    • Neurocritical Care
    • Neurogenetics
    • Neuro-Infectious Diseases
    • Neuromuscular
    • Neuro-Oncology
    • Neuro-Otology
    • Neurophysiology
    • Neuro-Rehabilitation
    • Sleep Disorders
    • Stroke
  • For Patients
    • Contact Us
    • Find a Doctor
    • Our Locations
    • Parking Guide for Westwood Clinic
    • Clinical Programs
    • Be part of Neurogenomics research
    • Patient Education
    • Referrals / Consults / Medical Records
  • Research Innovation
    • Mary S. Easton Center for Alzheimer's Disease Research at UCLA
    • Brain Mapping
    • Epilepsy
    • UCLA Goldberg Migraine Program
    • Health Services
    • Movement Disorders
    • Multiple Sclerosis
    • Neurogenetics
    • Clinical Neurogenomics Research Center (CNRC)
    • Neuro-Infectious Diseases
    • Neuromuscular
    • Neuro-Oncology
    • Neuro-Otology
    • Neuroscience Discovery
    • Neurophysiology
    • Neuro-Rehabilitation
    • Sleep Disorders
    • Stroke
  • Clinical Trials
  • Education
    • Residency
    • Fellowships
    • Research
    • Medical Students
    • Unique Programs
    • Education Leadership Team
    • Practice Locations
    • Contact Us
  • For Healthcare Professionals
    • Calendar
    • Referrals / Consults / Medical Records
    • Employment Opportunities
    • Find a Physician
    • News & Events
  • Faculty & Staff
    • Westwood Faculty
    • Faculty at Affiliated and Partner Sites
    • Community Neurologists
    • Staff Providers
    • Fellows
    • Residents
    • Researchers
    • Voluntary Faculty
    • Emeritus Faculty
    • Research Trainees
    • Admin Staff
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Neurology

Research Innovation

Research Innovation

Research Innovation

  • Mary S. Easton Center for Alzheimer's Disease Research at UCLA
    • Clinical Program
  • Brain Mapping
  • Epilepsy
    • Clinical Program
    • Fellowship
    • Outreach Research
  • UCLA Goldberg Migraine Program
    • Clinical Program
  • Health Services
  • Movement Disorders
    • Clinical Program
    • Fellowship
  • Multiple Sclerosis
    • Clinical Program
    • Fellowship
  • Neurogenetics
    • Clinical Program
    • Fellowship
  • Clinical Neurogenomics Research Center (CNRC)
  • Neuro-Infectious Diseases
    • Clinical Program
  • Neuromuscular
    • Fellowship
    • Clinical Program
    • Clinical Trials
  • Neuro-Oncology
    • Fellowship
    • Clinical Program
  • Neuro-Otology
    • Fellowship
    • Clinical Program
  • Neuroscience Discovery
  • Neurophysiology
    • Fellowship
    • Clinical Program
  • Neuro-Rehabilitation
    • Fellowship
    • Clinical Program
  • Sleep Disorders
    • Clinical Program
  • Stroke
    • Fellowship
    • Clinical Program
  • Mary S. Easton Center for Alzheimer's Disease Research at UCLA
  • Brain Mapping
  • Epilepsy
  • UCLA Goldberg Migraine Program
  • Health Services
  • Movement Disorders
  • Multiple Sclerosis
  • Neurogenetics
  • Clinical Neurogenomics Research Center (CNRC)
  • Neuro-Infectious Diseases
  • Neuromuscular
  • Neuro-Oncology
  • Neuro-Otology
  • Neuroscience Discovery
  • Neurophysiology
  • Neuro-Rehabilitation
  • Sleep Disorders
  • Stroke
  • Fellowship
  • Clinical Program
  1. Home
  2. Research Innovation
  3. Neuro-Oncology

Neuro-Oncology Research

Share this

The UCLA Neuro-oncology Program conducts extensive translational and clinical research focused on individualizing treatments to extend and improve the lives of patients with primary brain tumors. The program faculty members often collaborate with other investigators in the UCLA Brain Tumor Center and are part of the brain cancer SPORE.

Basic and Translational Research:
UCLA Brain Tumor Center Research

Additional Information - Neuro-Oncology Program:
Neuro-Oncology Program
The Lai Lab


Clinical Trials

Neuro-Oncology clinical trials include advanced treatment modalities for brain cancer including targeted therapies, viral therapies, and immunotherapies. Other clinical trials include studies in tumor imaging, quality of care, and neurocognition in collaboration with other researchers at UCLA Health.

For questions on clinical trials, contact:
Emese Filka
Clinical Trial Coordinator
310-794-3521

You may find more information on the following clinical trials offered by our program at ClinicalTrials.gov

UCLA - IRB Number Study Agent Targeted Pathology Diagnosis Trial Phase

#14-000514

Lapatinib with Surgery

Recurrent High-Grade Glioma

Early Phase

#14-000800

MLN0128 with Surgery

Preoperative Recurrent Glioblastoma (GBM)                                          

Pilot Study

#15-001667

ACP-196

Recurrent GBM

Phase 1b/2

#16-000207

Nivolumab vs Temozolomide, with RT

Newly Diagnosed GBM

Phase 3

#16-000365

Temozolomide plus Radiation  Therapy (RT) Combined with Nivolumab

Newly Diagnosed GBM

Phase 2

#16-000464

IL-7 (CYT107)

High Grade Gliomas

Pilot Study

#16-000576

DNX-2401 with Pembrolizumab

1st or 2nd Recurrent GBM or Gliosarcoma

Phase 2

#16-000649

ABT-414 with Concurrent Chemoradiation and Adjuvant Temozolomide

Newly Diagnosed GBM

Phase 2b/3

#16-001865

Pembrolizumab

Recurrent Malignant Glioma

Pilot Study

#16-001874

Abemaciclib

Recurrent GBM

Phase 2

#17-000338

Avelumab with HFRT

Recurrent GBM transformed from low grade glioma

Phase 2

#17-000756

PT2385

Recurrent GBM

Phase 2

#17-000758

Anti-LAG-3 or Anti-CD137 in Combination with Anti-PD-1

Recurrent GBM

Phase 1

#17-000794

DSP-7888 with Bevacizumab

Recurrent GBM

Phase 2

#17-000998

BGB-290 with Temozolomide and/or RT

Newly Diagnosed GBM or 1st Recurrent GBM

Phase 1b/2

#17-001423

AMG596

Newly Diagnosed GBM or Recurrent GBM

Phase 1

#17-001719

AG120 or AG881, with surgery

Recurrent Grade 2 or 3 Low Grade Glioma

Phase 1


Director

Timothy F. Cloughesy, MD
Timothy F. Cloughesy, MD

Faculty

Albert Lai, MD, PhD
Albert Lai, MD, PhD
Phioanh Leia Nghiemphu, MD
Phioanh Leia Nghiemphu, MD

Donate Today   Giving: Your gift to the UCLA Neuro-Oncology Program makes a difference.

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth